About
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.
Tags
Total Employees
20
Current headcount
Performance
Company Timeline
No timeline data for this period
Score Breakdown
54Traction
47Team
90Visibility
32Profile
80Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Mana.bio do?
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.
How much funding has Mana.bio raised?
Mana.bio has raised a total of $20M in funding. The most recent round on record is Seed.
When was Mana.bio founded?
Mana.bio was founded in 2021.
What industry does Mana.bio operate in?
Mana.bio operates in Life Sciences, Drug Delivery, mRNA, Lipid Nanoparticle (LNP), Therapeutics, Biotech.
How many employees does Mana.bio have?
Mana.bio has approximately 20 people on record.